Ko Eungil, Lee Yaelim
Department of Nursing, Asan Medical Center, Seoul, Republic of Korea.
College of Nursing, The Catholic University of Korea, Seoul, Republic of Korea.
Asia Pac J Oncol Nurs. 2024 Jul 23;11(9):100562. doi: 10.1016/j.apjon.2024.100562. eCollection 2024 Sep.
This study aimed to perform a meta-analysis of randomized control trials to evaluate the effects of cognitive behavioral therapy on depression, anxiety, fatigue, distress, the fear of cancer recurrence, and the quality of life in gynecological cancer patients.
An extensive literature search of PubMed, Web of Science, Scopus, and CINAHL was performed, and a meta-analysis was conducted on ten studies that included 1027 patients. The quality of the data was evaluated using the Cochrane Risk of Bias tool. The effect size of the mean difference and standardized mean difference were computed using Revman 5.4.1.
Gynecological cancer patients receiving cognitive behavioral therapy showed decreases in depression ( < 0.001), anxiety ( = 0.01), fatigue ( < 0.001), distress ( = 0.03), and the fear of cancer recurrence ( = 0.01) compared to those receiving no treatment, whereas no improvement in quality of life was seen in the cognitive behavioral therapy group ( = 0.05).
Cognitive behavioral therapy was shown to be a useful treatment for the symptoms experienced by women with gynecological cancer, with significant effect sizes. However, more research is required to validate the efficacy of cognitive behavioral therapy in patients with gynecological cancer, considering the limitations of this study's small sample size and statistical heterogeneity.
PROSPERO- CRD42024516039.
本研究旨在对随机对照试验进行荟萃分析,以评估认知行为疗法对妇科癌症患者的抑郁、焦虑、疲劳、痛苦、癌症复发恐惧及生活质量的影响。
对PubMed、科学网、Scopus和CINAHL进行广泛的文献检索,并对纳入1027例患者的10项研究进行荟萃分析。使用Cochrane偏倚风险工具评估数据质量。使用Revman 5.4.1计算平均差和标准化平均差的效应量。
与未接受治疗的患者相比,接受认知行为疗法的妇科癌症患者在抑郁(<0.001)、焦虑(=0.01)、疲劳(<0.001)、痛苦(=0.03)和癌症复发恐惧(=0.01)方面有所降低,而认知行为疗法组的生活质量未见改善(=0.05)。
认知行为疗法被证明是治疗妇科癌症女性患者症状的有效方法,效应量显著。然而,考虑到本研究样本量小和统计异质性的局限性,需要更多研究来验证认知行为疗法对妇科癌症患者的疗效。
PROSPERO-CRD42024516039。